[india-drug] Drug information centre in Mumbai

[Sunitha Srinivas <s.srinivas@ru.ac.za>]

Source: 
http://www.pharmabiz.com/article/detnews.asp?articleid=19818&sectionid=
Thanks?SS

It would be nice if we have the email ID or contact details of this
DIC. Would help all of us to get in touch when we have queries. Idrug
participants from Maharashtra are requested to pl pursue this and let
us know about the contact details of the DIC.Thanks....SS)


State pharmacy council sets up drug information centre in Mumbai, third
in India
-----------------------------------------------------------------------

Friday, January 09, 2004 08:00 IST 
Our Bureau, Mumbai

The Maharashtra State Pharmacy Council has set up a Drug Information
Centre (DIC) in Mumbai to help doctors and pharmacists get in-depth and
focused drug information. The DIC will also be useful to the medical
fraternity in monitoring adverse drug reactions (ADRs) by using
powerful medical database so as to improve patient compliance. An
important objective of DIC is to promote Rational Use of Drugs. 

DIC is an established concept in clinical practice in most developed
countries. The concept is only taking shape in India in recent years.
Latest information is the key to prevent medication errors. Such
information leads to Enhanced Quality of Patient Care and thus Improved
Patient Outcome.

With rapid advancement in medical and biological science, there is a
huge flow of information about new drugs and diseases. Access and
authenticity to verify this vast information flow being limited,
rational selection and utilization of drugs has been complex for the
doctors and pharmacists. The conventional method of obtaining drug
information is through the medical representatives and product
literature provided by the manufacturers, which in many cases are
incomplete or biased. 

MSPC's centre is the third DIC in India and the first one in western
region of the country. DIC would also serve the poor people, to bring
down the burden of health problem on the society through continuous
education. The DIC will also be assisting doctors and hospital
pharmacists in updating new drugs emerging at international level, in
different therapeutic areas. 

DIC will respond to your queries on: (free service)
1. Drug or its Product Information/Identification
2. Contraindications/Safety
3. Adverse Drug Reactions/Drug Interactions
4. Efficacy/Treatment/Choice of drug
5. Pregnancy/Lactation/Pediatrics
6. Drug Profile/Indications/Dosage
7. Toxicology

Information furnished by DIC will be fully authentic and retrieved
mainly from internationally reputed database (Micromedex's Drugdex,
USA) and it will be delivered through any desired mode of
communication. Drugs related queries can be sent by email, phone or
post or in person and DIC will respond to it immediately.




________________________________________________________________________
Yahoo! India Mobile: Download the latest polyphonic ringtones.
Go to http://in.mobile.yahoo.com

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org